marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Oramed Pharmaceuticals Cash Flow 2011-2024 | ORMP
Annual Cash Flow Oramed Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-10.3 M | -27.9 M | -11.1 M | -12.4 M | -12.9 M | -14.7 M | -5.83 M | 4.66 M | -4.95 M | -4.07 M | -3.4 M | -2.3 M | -1.71 M |
Depreciation & Amortization |
196 K | 58 K | 18 K | 7 K | 8 K | 6 K | 5 K | 4 K | 4 K | 6 K | 5 K | 15 K | 28.3 K |
Accounts Payables |
1.61 M | 4.16 M | 4.54 M | 1.7 M | 2.54 M | 2.06 M | 2.72 M | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | 87.7 K | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Oramed Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -1.48 M | - | - | - | -5.55 M | - | -19.9 M | -17.6 M | -9.12 M | -11.1 M | -13.9 M | -8.35 M | -6.9 M | -8.26 M | -9.98 M | -6.62 M | -6.15 M | -3 M | -9.67 M | -6.02 M | -3 M | -4.13 M | -10 M | -6.2 M | -4.13 M | -2.73 M | -3.78 M | -1.43 M | -2.73 M | 1.5 M | -2.15 M | 77 K | 1.5 M | -2.25 M | -3.92 M | -3 M | -2.25 M | -1.4 M | -3.27 M | -2.23 M | -1.4 M | -748 K | -3.12 M | -2.07 M | -749 K | -793 K | -1.96 M | -1.08 M | -793 K | -484 K | -1.28 M | -695 K | -467 K |
Depreciation & Amortization |
- | - | 56 K | - | - | - | 37 K | - | 41 K | 26 K | 11 K | 18 K | 69 K | 54 K | 12 K | 7 K | 5 K | 2 K | 2 K | - | 4 K | 4 K | - | 2 K | 4 K | 3 K | 2 K | 1 K | 4 K | 2 K | 1 K | 1 K | 3 K | 2 K | 1 K | 1 K | 4 K | 3 K | - | 1 K | 4 K | 3 K | 1 K | 2 K | 3.7 K | 2.9 K | 128 K | 2.27 K | 17.4 K | 11.7 K | 2.27 K | 6.04 K | 22.8 K | 15.1 K | 6.04 K |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | - | 3.79 M | - | - | - | 1.7 M | - | - | - | 2.54 M | - | - | - | 2.06 M | - | - | 2.6 M | 2.72 M | - | 2.72 M | - | 1.41 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 334 K | 440 K | 76 K | 87.7 K | 87.7 K | 87.7 K | 86 K | 543 K | 543 K | 543 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency